Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics
Volume 10, Issue 4, July 2023, Pages 1367-1401
The Nuclear Factor Kappa B (NF-kB) signaling in cancer development and immune diseases
Volume 8, Issue 3, May 2021, Pages 287-297
Age-related macular degeneration: Epidemiology, genetics, pathophysiology, diagnosis, and targeted therapy
Volume 9, Issue 1, January 2022, Pages 62-79
CCL5/CCR5 axis in human diseases and related treatments
Volume 9, Issue 1, January 2022, Pages 12-27
The biogenesis and secretion of exosomes and multivesicular bodies (MVBs): Intercellular shuttles and implications in human diseases
Volume 10, Issue 5, September 2023, Pages 1894-1907
Targeting RAS–RAF–MEK–ERK signaling pathway in human cancer: Current status in clinical trials
Volume 10, Issue 1, January 2023, Pages 76-88
Critical roles of FTO-mediated mRNA m6A demethylation in regulating adipogenesis and lipid metabolism: Implications in lipid metabolic disorders
Volume 9, Issue 1, January 2022, Pages 51-61
HIF-1α signaling: Essential roles in tumorigenesis and implications in targeted therapies
Volume 11, Issue 1, January 2024, Pages 234-251
Canonical and noncanonical Wnt signaling: Multilayered mediators, signaling mechanisms and major signaling crosstalk
Volume 11, Issue 1, January 2024, Pages 103-134
Wnt signaling: Essential roles in osteoblast differentiation, bone metabolism and therapeutic implications for bone and skeletal disorders
Volume 10, Issue 4, July 2023, Pages 1291-1317
NADPH debt drives redox bankruptcy: SLC7A11/xCT-mediated cystine uptake as a double-edged sword in cellular redox regulation
Volume 8, Issue 6, November 2021, Pages 731-745
Non-small cell lung carcinoma (NSCLC): Implications on molecular pathology and advances in early diagnostics and therapeutics
Volume 10, Issue 3, May 2023, Pages 960-989
Molecular subtypes of colorectal cancer: An emerging therapeutic opportunity for personalized medicine
Volume 8, Issue 2, March 2021, Pages 133-145
Pretreating and normalizing metabolomics data for statistical analysis
Volume 11, Issue 3, May 2024, Page
A new emerging target in cancer immunotherapy: Galectin-9 (LGALS9)
Volume 10, Issue 6, November 2023, Pages 2366-2382
Mitochondrial dysfunction: A promising therapeutic target for liver diseases
Volume 11, Issue 3, May 2024, Page
The critical roles of m6A modification in metabolic abnormality and cardiovascular diseases
Volume 8, Issue 6, November 2021, Pages 746-758
Cancer cell cycle heterogeneity as a critical determinant of therapeutic resistance
Volume 11, Issue 1, January 2024, Pages 189-204
Oridonin and its derivatives for cancer treatment and overcoming therapeutic resistance
Volume 8, Issue 4, July 2021, Pages 448-462
Cancer: An unknown territory; rethinking before going ahead
Volume 8, Issue 5, September 2021, Pages 655-661
Targeting LIF/LIFR signaling in cancer
Volume 9, Issue 4, July 2022, Pages 973-980
The evolving roles of Wnt signaling in stem cell proliferation and differentiation, the development of human diseases, and therapeutic opportunities
Volume 11, Issue 3, May 2024, Page
Inflammation and cancer: paradoxical roles in tumorigenesis and implications in immunotherapies
Volume 10, Issue 1, January 2023, Pages 151-164
Ribonucleotide reductase M2 (RRM2): Regulation, function and targeting strategy in human cancer
Volume 11, Issue 1, January 2024, Pages 218-233
Regulation of ferroptosis in cancer cells by YAP/TAZ and Hippo pathways: The therapeutic implications
Volume 8, Issue 3, May 2021, Pages 241-249
